ASNC2017 On Demand (52.25 CME credits)


This On Demand activity is comprised of sessions and presentations from the live ASNC2017 22nd Annual Scientific Meeting September 14-17, 2017 in Kansas City, MO. The focus of ASNC2017 meeting is to showcase current best practices, new ideas and emerging technology, radiation safety and appropriate use criteria in the nuclear cardiology clinical practice.

The ASNC2017 Online Library showcases what nuclear cardiology has to offer to provide the best care to patients.In this year’s program, physicians can refine diagnostic and technical skills in choosing the right test for the right patient and affording the lowest radiation dose possible.Sessions on multimodality imaging will provide essential diagnostic information in an environment of health care cost containment.Cardiac PET and SPECT imaging sessions are showing state-of-the-art innovations in perfusion imaging, quantification of myocardial blood flow reserve, and the diagnosis of inflammatory and infiltrative cardiomyopathies.World renowned experts are truly covering a variety of disease-specific imaging topics of interest to professionals performing cardiac imaging studies.

Eligible for 52.25 CME Credits

ASNC2017 Scientific Sessions On Demand features easy online access anywhere, anytime from your smartphone,tablet or computer! The media player includes audio files w/presentation slides, select video, unlimited playback, evaluations for clock hours, downloadable materials, and a full support team for your convenience.

NEW this year- includes video recordings of 10 select sessions.

ASNC2017 22nd Annual Scientific Session On Demand

Overall Description

This On Demand activity is comprised of sessions and presentations from the live ASNC2017 22nd Annual Scientific Meeting September 14-17, 2017 in Kansas City, MO. The focus of ASNC2017 meeting is to showcase current best practices, new ideas and emerging technology, radiation safety and appropriate use criteria in the nuclear cardiology clinical practice.

Activity Release Date: October 27, 2017
Date of Release: October 27, 2017
Date of Last Review: September 17, 2017
Date of Termination: October 26, 2018

Estimated time to complete this activity is 8.5 hours.

Statement of Need

In order to maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2017 is an educational activity designed to help you and other imaging professionals obtain the latest information in clinical practice and review cutting-edge scientific advances in nuclear cardiology and cardiac imaging.

Overall Purpose:

The overall goal of this activity is to enhance physician knowledge, competence and skills in applications about appropriate use criteria, radiation safety, reporting, and lab performance in using appropriate guidelines-based treatment.

Learning Objectives:

  • Demonstrate improved skills in image interpretation and reporting
  • Learn how to recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
  • Learn the appropriate use of cardiac imaging techniques based on current guidelines
  • Evaluate new imaging technologies, software, and stress techniques
  • Understand the role of nuclear and cardiac CT imaging in overall patient care
  • Learn the importance of balancing radiation exposure with image quality
  • Describe future directions in cardiac PET, CT, and SPECT/CT in order to anticipate training and equipment needs
  • Understand the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology

Target Audience

This online activity is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses and other health care professionals with an interest in the field of nuclear cardiology and cardiac CT imaging.

Accreditation and Continuing Education Credit

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for a maximum of 52.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planners

Organizing Committee

Prem Soman, MD, PhD, FASNC, Chair
Firas Al Badarin, MD, FASNC
Karthikeyan Ananthasubramaniam, MD, FASNC
Timothy L. Dunn, CNMT

.

.


Brian G. Abbott, MD, MASNC
Raymond R. Russell, MD, PhD, FASNC
Randall C. Thompson, MD, FASNC

.

Program Committee

Donna M. Polk, MD, MPH, FASNC, Chair
Sharmila Dorbala, MD, FASNC, Vice Chair
James A. Arrighi, MD, MASNC
Rob S.B. Beanlands, MD, FASNC
Jamieson M. Bourque, MD, FASNC
Renee Bullock-Palmer, MD, FASNC
Dennis Calnon, MD, FASNC
Panithaya Chareonthaitawee, MD
Marcelo Di Carli, MD
Jane Dunne (ASNC staff)
Andrew J. Einstein, MD, PhD, FASNC
Oliver Gaemperli, MD
Fadi Hage, MD, FASNC
Christopher L. Hansen, MD, FASNC
Matthew E. Harinstein, MD
Gary V. Heller, MD, PhD, MASNC
Edward Hulten, MD, MPH, FASNC

.

Juhani Knuuti, MD, PhD
April Mann, MBA, CNMT, RT(N), NCT, FASNC
Edward J. Miller, MD, PhD, FASNC
Todd D. Miller, MD
Khurram Nasir, MD, MPH
Robert A. Pagnanelli, CNMT, RT(N)(R), FASNC
Mi-Ae Park, PhD
Matthew Parker, MD
Lawrence M. Phillips, MD, FASNC
Raymond R. Russell, III, MD, PhD, FASNC
Ibrahim M. Saeed, MD
Maria G. Sciammarella, MD
Nishant R. Shah, MD, MPH
Albert J. Sinusas, MD, FASNC
Mark I. Travin, MD, FASNC
James E. Udelson, MD, MASNC



Disclosure

As an Accreditation Council for Continuing Medical Education (ACCME) accredited continuing medical education (CME) provider, ASNC must insure balance, independence, objectivity, and scientific rigor in all of its continuing medical education activities. In order to achieve these goals, we require everyone who is in a position to control the content of an educational activity to disclose to us all relevant financial relationships with any commercial interest. These relationships are those in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected. We also consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. With respect to personal financial relationships, ‘contracted research’ includes research funding where the institution receives the grant and manages the funds and the person is the principal or named investigator on the grant. Relevant financial relationships are financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. In addition, should it be determined that a conflict of interest exists as a result of a financial relationship a planner or a speaker may have, it will be resolved prior to the activity. ASNC also requires that all faculty presenters disclose their intent to discuss any unlabeled/unapproved uses of drugs and/or devices during their presentations.

1 designates presenter
2 designates peer reviewer/moderator
3 designates planner

The following individuals have stated that they have no relevant financial relationships with any commercial interest that produces health care goods or services, including computer software/hardware, related to the content of the educational presentation in which they are involved:

1,2Abbott, Brian
1,3Abdel Fattah, Alia
1,3Alexanderson, Erick
1,2,3Ananthasubramaniam, Karthik
1,2,3Arrighi, James
1,3Arumugam, Parthiban
1Dhar, Ritesh
1,3Dietz, Joseph
1,2,3Dunn, Timothy
2Dunne, Jane
1,2Flood, Kathleen
2Gaemperli, Oliver
1Gerson, Myron
1Gould, K. Lance
1Hachamovitch, Rory
1,2Harinstein, Matthew
1,2,3Heller, Gary
1,3Holly, Thomas
1,2Hulten, Edward
1,3Hyun, Mark
1,3Iskandrian, Ami
1,3Keng, Felix

1Cooper, Leslie
1,3Costello, Maria
1,3Cremer, Paul
1,3Delbeke, Dominique
1DePuey, E. Gordon
1Dhar, Ritesh
1,3Dietz, Joseph
1,2,3Dunn, Timothy
2Dunne, Jane
1,2Flood, Kathleen
2Gaemperli, Oliver
1Gerson, Myron
1Gould, K. Lance
1Hachamovitch, Rory
1,2Harinstein, Matthew
1,2,3Heller, Gary
1,3Holly, Thomas
1,2Hulten, Edward
1,3Hyun, Mark
1,3Iskandrian, Ami
1,3Keng, Felix
2Knuuti, Juhani
1Kudo, Takashi
1,2Lawrence, Georgia
1,3Leppo, Jeffrey
1,3Lundbye, Justin
1,3Majmundar, Haresh
1,3Malhotra, Saurabh
1Masri, Ahmad
1Masuda, Atsuro
1,3McGhie, A. Iain
1,3Miller, Todd
2Nasir, Khurram
1Oakes, Lisa
1Omer, Mohamed
1,2Park, Mi-Ae
1,2,3Phillips, Lawrence
1,2,3Polk, Donna
1Port, Steven
1,3Ruddy, Terrence
1,2,3Saeed, Ibrahim
1Salerno, Michael
1,3Schockling, Eric
1,3Sciammarella, Maria
1Shaw, Leslee
1,2Sinusas, Albert
1Small, Gary
1,3Skali, Hicham
1,3Sobal, Larry
1Stacy, Mitchel
1Tamarappoo, Balaji K.
1,3Taqueti, Viviany
1,2,3Thompson, Randall
1Toczek, Jakub
1,3Tilkemeier, Peter
1,2,3Travin, Mark
1,3Van Decker, William
1Veeranna, Vikas
1,3Verberne, Hein
1,3Vitola, Joao
1,3Wann, L Samuel
1Ward, Parker
1,3Warren, Jaime
1,3Williams, Kim
1Wu, Katherine
1Zaret, Barry
1Ziffer, Jack

Relevant financial relationships with commercial interests have been stated as noted by the following planners, presenters and moderators:

2Al Badarin, Firas
Speakers Bureau: Lantheus

1Alexander, Kevin
Research Grant or Contractor:
Principal investigator for an investigator-initiated research grant from Pfizer (2017 ASPIRE Transthyretin Amyloidosis Competitive Research Grant Award)

1Allam, Adel
Salaried Employee: CEO of an Egyptian Medical company. Annual salary 30,000 $.

1Al-Mallah, Mouaz
Consulting Fee: Pfizer
Honoraria: Pfizer, Novartis

1Arai, Andrew
Research Grant or Contractor:
Siemens, Bayer

1,3Bateman, Timothy
Intellectual Property Rights: CVIT
Honoraria: Bracco
Research Grant or Contractor: Astellas GE
Advisory Board: AIM
Royalty: CVIT
Stock Interest: CVIT

2Beanlands, Rob
Consulting Fee: Lantheus Medical Imaging Jubilant DRAXImage
Research Grant or Contractor:
Lantheus Medical Imaging Jubilant
DRAXImage, GE Healthcare

1Berman, Daniel
Research Grant or Contractor: Astellas
Royalty: Cedars-Sinai

1,3Blankstein, Ron
Consulting Fee: EKOS Corp., Stealth Peptides
Research Grant or Contractor: Amgen, Gilead
Advisory Board: Amgen

1,2,3Calnon, Dennis
Consulting Fee: Navidea
Biopharmaceuticals
Research Grant or Contractor:

1Case, James
Intellectual Property Rights: CVIT
Research Grant or Contractor: Astellas, General Electric
Stock Interest: CVIT
Salaried Employee: CVIT

1,3Cerqueira, Manuel
Consulting Fee: Astellas Scientific
Advisory Board: Astellas Pharma USA
Speakers Bureau: Astellas Pharma USA

1deKemp, Robert
Intellectual Property Rights: Ottawa Heart Inst.
Consulting Fee: Jubilant Draximage
Research Grant or Contractor: Jubilant Draximage
Royalty: Ottawa Heart Inst.

1,2Di Carli, Marcelo
Research Grant or Contractor: Spectrum Dynamics
Advisory Board: Sanofi

1Dilsizian, Vasken
Research Grant or Contractor: GE Healthcare, Siemens

1,2,3Dorbala, Sharmila
Research Grant or Contractor: Astellas
Stock Interest: General Electric

1,3Doukky, Rami
Research Grant or Contractor: Astellas
Advisory Board: Astellas

1,3Druz, Regina
Intellectual Property Rights: iVisitMD software designed by me to offer patients on-demand access.
Speakers Bureau: Astellas pharma
Owner: My own practice Integrative Cardiology PLLC

1Duvall, W. Lane
Research Grant or Contractor: Physician initiated
study grant - Astellas

1,2,3Einstein, Andrew
Consulting Fee: GE Healthcare
Research Grant or Contractor: Philips, Toshiba

1Fialkow, Jonathan
Advisory Board: BMS, Amgen, Amorin

1,3Garcia, Ernest
Intellectual Property Rights: Emory cardiac toolbox (ECTb)
Consulting Fee: Syntermed
Research Grant or Contractor: Syntermed
Royalty: Royalties for ECTb
Stock Interest: Shares of syntermed

1,3Garcia Mario
Royalty: Elsevier, Wolters-Kluwer
Stock Interest: Pfizer

1Gibbons, Raymond
Consulting Fee: Astellas Pharmaceuticals Peer View Institute

1,3Gropler, Robert
Consulting Fee: Sanofi
Research Grant or Contractor: Bayer, NIH, Biomedical

1,2Hage, Fadi
Research Grant or Contractor: Astellas, Novartis

1,2,3Hansen, Christopher
Consulting Fee: Digirad
Royalty: General Electric

1,3Hendel, Robert
Consulting Fee: Astellas Pharma
Speakers Bureau: Astellas Pharma

1Hundley, W. Gregory
Intellectual Property Rights: Prova
Stock Interest: Prova

1,3Hyafil, Fabien
Consulting Fee: Naogen
Honoraria: Curium

1Johnson, Nils
Intellectual Property Rights: institution has 510(k) software related to cardiac PET: cfrQuant (K113754) and HeartSee (K143664) that I helped develop.
Consulting Fee: institution has a licensing and consulting agreement with Boston Scientific for the smart-minimum FFR algorithm that I helped develop.
Research Grant or Contractor: My institution has received research support from Volcano/Philips

1Kijewski, Marie
Stock Interest: Aeolus Pharmaceuticals, Microsoft, Fortive Corp, Roper Technologies

1Maddahi, Jamshid
Consulting Fee: Lantheus Medical Imaging, Astellas
Research Grant or Contractor: Lantheus Medical Imaging
Speakers Bureau: Astellas

1,3Mahmarian, John
Consulting Fee: Astellas, Inc
Speakers Bureau: Astellas, Inc

2Mann, April
Advisory Board: Astellas Pharma USA

1Merlino, Denise
Consulting Fee: Consulting for ASNC, SNMMI and other professional societies, Bracco, Pharmalucence
Salaried Employee: Husband works for Pharmalucence

1,2,3Miller, Edward
Consulting Fee: GE, Inc
Research Grant or Contractor: Bracco, Inc

1Murthy, Venkatesh
Honoraria: Bracco, Ionetix
Research Grant or Contractor: IAC, SNMMI, INVIA
Stock Interest: General Electric

1,2,3Pagnanelli, Robert
Speakers Bureau: Astellass

1,3Parker, Matthew
Consulting Fee: Intersocietal Accreditation
Commission-PET/Nuclear peer review

1,3Poornima, Indu
Speakers Bureau: Astellas

1Ruberg, Frederick
Consulting Fee: Caelum Biosciences, Prothena, Alnylam Pharmaceuticals

1,2,3Russell, Raymond
Stock Interest: Novartis (spouse)
Salaried Employee: Novartis (spouse)

1Sadeghi, Mehran
Consulting Fee: Bracco
Salaried Employee: Boehringer Ingelheim

1,3Schindler, Thomas
Research Grant or Contractor: Research grant from Siemens Medical Solutions to evaluate the image quality of cardiac perfusion studies with the novel Intevo -SPECT/CT.

1Scholte, Arthur
Consulting Fee: Toshiba Medical Systems
Advisory Board: GE Healthcare

1Schwartz, Ronald
Speakers Bureau: Astellas Pharma

1Shah, Amil
Advosory Board: Philips

1,3Shah, Nishant
Stock Interest: General Electric

1Slomka, Piotr
Research Grant or Contractor: NIH, Siemens

1,2,3Soman, Prem
Research Grant or Contractor: Astellas
Advisory Board: Alnylam Pharma

1,3Thomas, Gregory S.
Consulting Fee: Astellas Pharma IMV Medical Information
Research Grant or Contractor: Sanofi Amgen
Speakers Bureau: Astellas Pharma

1,2,3Udelson, James
Advisory Board: Lantheus

1Werner, Rudolf
Research Grant or Contractor: EU Framework’s Program

1,3Winchester, David
Research Grant or Contractor: Roche Diagnostics

1Wolinsky, David
Consulting Fee: Astellas Pharma
Honoraria: Astellas Pharma Speaker's Bureau
Advisory Board: Astellas Pharma
Speakers Bureau: Astellas Pharma

Disclaimer
The information in this activity represents the opinion of the faculty and is not necessarily the official position of ASNC.

Commercial Acknowledgement

This activity has not received commercial support.

Policy on Off Label Use

Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

Method of Participation and CME Certificates
To receive CME credit for this product, you must:

This product offers up to 52.25 CME credits, based on the number of hours you spend watching presentations and taking the post-test questions.

  1. Purchase the product.
  2. Read the CME front matter.
  3. View the session(s) of your choosing.
  4. Click the CE Information tab on individual sessions, and the Test button.
  5. Complete the post-test. Your must score 75% to earn credit. You may take the test as many times as you need to score 75%.
  6. When you are finished watching the session of your choosing, your certificate will reflect the total accumulated credits from the session. Generate and print your CME certificate.
  7. If you would like a transcript, or a breakdown of all credits claimed across all the ASNC2017 content, visit the My Account area and click on the tab on the left labeled Certificates and Transcripts. As you take more sessions, this transcript will automatically update with the additional credtis.

Medium or Combination of Medium Used:
This is an on demand activity with slides synchronized with audio.

Commercial Acknowledgement
This activity has not received commercial support

Hardware/Software Requirements
For the most current list of system requirements, please visit http://asnc.digitellinc.com/asnc/support/faq

For technical support please contact:

support@digitellinc.comor (716)338-0332 ; Toll Free (877)796-1325 (U.S.A. only)

ASNC Contact Information:

American Society of Nuclear Cardiology
4340 East-West Highway, Suite 1120
Bethesda, MD 20814-4578
Phone: (301) 215-7575
Fax: (301) 215-7113
info@asnc.org

Privacy Policy

This website is provided by Digitell Inc. We do not share information about individuals with anyone other than the credit card processors and the shipping company.

The complete Privacy Policy can be found by clicking Privacy Policy at the bottom of http://asnc.digitellinc.com/asnc.

Members: $599.00
Standard: $799.00

Products

How to Incorporate Test Findings Beyond Perfusion

Preview Available

How to Incorporate Test Findings Beyond Perfusion


Learning Objectives:

  • Recognize the value of non-imaging stress test variables including abnormal heart rate responses associated with exercise and exercise hypotension
  • Be better able to manage patients who have a positive EKG and normal MPI after stress testing

13:00 - 13:20 - Significant ST Segment Changes

13:20 - 13:40 - Arrhythmias, Heart Rate Recovery and Abnormal Hemodynamic Responses

13:40 - 14:00 - High Risk MPI Markers

14:00 - 14:20 - Coronary Artery Calcium and Coronary Flow Reserve

14:20 - 14:30 - Discussion

Moderator(s): Speaker(s):
Tags: Core

Positioning your Nuclear Cardiology Laboratory for Long-term Success:  A Comprehensive Boot Camp for Heart Service Line Administrators, Laboratory Managers, and Nuclear Cardiologists - Part 1

Preview Available

Positioning your Nuclear Cardiology Laboratory for Long-term Success: A Comprehensive Boot Camp for Heart Service Line Administrators, Laboratory Managers, and Nuclear Cardiologists - Part 1


Learning Objectives:

  • By participating in this education activity, the audience will develop a better understanding of the optimal SPECT and PET equipment for a modern nuclear cardiology laboratory in 2017, and an understanding of optimal test selection and incorporation of appropriate use criteria into the daily operation of the laboratory

13:00 - 13:20 - Physician Supervision Requirements for Stress Testing in 2017

13:20 - 13:40 - What is the Ideal Staffing of a Nuclear Cardiology Laboratory?

13:40 - 14:00 - Do Nuclear Technologists Need Additional Training and Qualification to Perform PET, SPECT/CT, or PET/CT Imaging?

14:00 - 14:15 - How do we Know we are Billing Correctly?

14:15 - 14:30 - How to Work Effectively with RBM’s to Facilitate Prior Authorization?

Moderator(s): Speaker(s):
Tags: Other

CT, PET/CT and PET/MR Imaging to Assess Heart Disease

Preview Available

CT, PET/CT and PET/MR Imaging to Assess Heart Disease


Learning Objectives:

  • Consider whether atherosclerosis is a fundamental component of human aging or secondary to known and/or unknown risk factors

14:45 - 15:05 - Ancient to Current: CT in the Evaluation of Atherosclerosis in Populations

15:05 - 15:25 - PET/CT: Current Role and Opportunities for Advancement

15:25 - 16:00 - PET/MRI:Potential Indications and Challenges with PET/MR Program Development

Moderator(s): Speaker(s):

Positioning your Nuclear Cardiology Laboratory for Long-term Success:  A Comprehensive Boot Camp for Heart Service Line Administrators, Laboratory Managers, and Nuclear Cardiologists - Part 2

Preview Available

Positioning your Nuclear Cardiology Laboratory for Long-term Success: A Comprehensive Boot Camp for Heart Service Line Administrators, Laboratory Managers, and Nuclear Cardiologists - Part 2


Learning Objectives:

  • By participating in this education activity, the audience will develop a better understanding of the optimal SPECT and PET equipment for a modern nuclear cardiology laboratory in 2017, and an understanding of optimal test selection and incorporation of appropriate use criteria into the daily operation of the laboratory

14:45 - 15:05 - What is the Ideal Mix of SPECT and PET Equipment for the Modern Nuclear Cardiology Laboratory?

15:25 - 15:45 - How Can We Incorporate AUC into the Modern Nuclear Laboratory?

15:45 - 16:15 - Where is the Industry Heading and How Should we Position Ourselves to be Successful in the Value World?

Moderator(s): Speaker(s):
Tags: Other

The Changing Face of Medicare: Considerations in Practice and Payment

Preview Available

The Changing Face of Medicare: Considerations in Practice and Payment


Learning Objectives:

  • Consider how nuclear cardiologists can participate in the Bundled payment initiatives of the CMS Center for Medicare & Medicaid Innovation

16:15 - 16:25 - Introductory Remarks

16:25 - 16:35 - Coding Update

16:35 - 16:50 - MIPS/ MACRA- What you Need to Know

16:50 - 17:05 - Bundled Payments for Care Improvement Initiative (BCPI)

17:05 - 17:20 - Medicare’s Appropriate Use Criteria Program: an ASNC Status Update

17:20 - 17:35 - Legislative Update

17:35 - 17:50 - The AUC Mandate: An Alternative Perspective

17:50 - 18:00 - Discussion

Moderator(s): Speaker(s):
Tags: Policy

Opening Plenary and Verani Lecture

Preview Available

Opening Plenary and Verani Lecture


Learning Objectives:

  • Learn new directions in cardiac imaging in order to anticipate future needs

07:45 - 07:55 - Opening Remarks from the ASNC CEO

07:55 - 08:05 - Remarks from ASNC2017 Program Chair

08:05 - 08:20 - President's Address

08:20 - 08:25 - ASNC & ASE: Innovation Collaboration

08:25 - 08:45 - President Elect's Address

08:45 - 08:50 - Presentation of Kenneth Brown Award

08:50 - 08:55 - Introduction of Verani Lecturer

08:55 - 09:30 - Evolving, Innovating and Revolutionary Changes in Cardiovascular Imaging - We Have Only Begun

Moderator(s): Speaker(s):
Tags: Plenary

Imaging to Guide Arrhythmia Management

Preview Available

Imaging to Guide Arrhythmia Management


ASNC2017: Imaging Guide to Arrhythmia Management

Overall Description

This session of the live ASNC2017 22nd Annual Scientific Meeting September 14-17, 2017 in Kansas City, MO is focused on the diagnosis and management of patients presenting cardiac arrhythmias.

Activity Release Date: 10/27/2017
Activity Expiration Date: 10/26/2018
Activity Last Review Date: September 30, 2017

Estimated time to completion is 1.5 hr.

Statement of Need

In order to maintain competence and improve performance for best patient outcomes, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced.

Overall Purpose:
The overall goal of this activity is to enhance physician knowledge, competence and skills in applications about appropriate use criteria, radiation safety, reporting, and lab performance in using appropriate guidelines-based treatment.

Learning Objectives:

  • Describe clinical and imaging variables that increase susceptibility to lethal ventricular cardiac arrhythmias
  • Understand the role of cardiac MRI in the risk stratification of patients at risk for ventricular arrhythmias and for diagnosis and management of patients presenting with ventricular arrhythmias

Target Audience

This online activity is intended for cardiologists, radiologists, nuclear medicine specialists, and other health care professionals involved in the field of nuclear cardiology.

Accreditation and Continuing Education Credit

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASNC has achieved Accreditation with Commendation

Planners

Organizing Committee

Prem Soman, MD, PhD, FASNC, Chair
Brian G. Abbott, MD, MASNC
Firas Al Badarin, MD, FASNC
Karthikeyan Ananthasubramaniam, MD, FASNC

.

.

Timothy L. Dunn, CNMT
Raymond R. Russell, MD, PhD, FASNC
Randall C. Thompson, MD, FASNC

.

Program Committee

Donna M. Polk, MD, MPH, FASNC, Chair
Sharmila Dorbala, MD, FASNC, Vice Chair
James A. Arrighi, MD, MASNC
Rob S.B. Beanlands, MD, FASNC
Jamieson M. Bourque, MD, FASNC
Renee Bullock-Palmer, MD, FASNC
Dennis Calnon, MD, FASNC
Panithaya Chareonthaitawee, MD
Marcelo Di Carli, MD
Jane Dunne (ASNC staff)
Todd D. Miller, MD
Khurram Nasir, MD, MPH
Robert A. Pagnanelli, CNMT, RT(N)(R), FASNC
Mi-Ae Park, PhD
Matthew Parker, MD
Lawrence M. Phillips, MD, FASNC
Raymond R. Russell, III, MD, PhD, FASNC

.

.

Andrew J. Einstein, MD, PhD, FASNC
Oliver Gaemperli, MD
Fadi Hage, MD, FASNC
Christopher L. Hansen, MD, FASNC
Matthew E. Harinstein, MD
Gary V. Heller, MD, PhD, MASNC
Edward Hulten, MD, MPH, FASNC
Juhani Knuuti, MD, PhD
April Mann, MBA, CNMT, RT(N), NCT, FASNC
Edward J. Miller, MD, PhD, FASNC


.


.

.

.

Disclosure

As an Accreditation Council for Continuing Medical Education (ACCME) accredited continuing medical education (CME) provider, ASNC must insure balance, independence, objectivity, and scientific rigor in all of its continuing medical education activities. In order to achieve these goals, we require everyone who is in a position to control the content of an educational activity to disclose to us all relevant financial relationships with any commercial interest. These relationships are those in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected. We also consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. With respect to personal financial relationships, ‘contracted research’ includes research funding where the institution receives the grant and manages the funds and the person is the principal or named investigator on the grant. Relevant financial relationships are financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. In addition, should it be determined that a conflict of interest exists as a result of a financial relationship a planner or a speaker may have, it will be resolved prior to the activity. ASNC also requires that all faculty presenters disclose their intent to discuss any unlabeled/unapproved uses of drugs and/or devices during their presentations.

1 designates presenter
2 designates peer reviewer/moderator
3 designates planner

The following individuals have stated that they have no relevant financial relationships with any commercial interest that produces health care goods or services, including computer software/hardware, related to the content of the educational presentation in which they are involved:

1,2Abbott, Brian
1,2,3Ananthasubramaniam, Karthik
1,2,3Arrighi, James
1,2,3Bourque, Jamieson
1,2,3Bullock-Palmer, Renee
1,2,3Chareonthai
awee, Panithaya

1,2,3Dunn, Timothy
2Dunne, Jane
2Gaemperli, Oliver
1,2Harinstein, Matthew
1,2,3Heller, Gary
1,2Hulten, Edward
2Knuuti, Juhani
1,3Miller, Todd

2Nasir, Khurram
1,2Park, Mi-Ae
1,2,3Phillips, Lawrence
1,2,3Polk, Donna
1,2,3Saeed, Ibrahim
1,3Sciammarella, Maria
1,2Sinusas, Albert
1,2,3Thompson, Randall

1,2,3Travin, Mark
1,3Verberne, Hein
1Wu, Katherine

.

.

.

.

.

Relevant financial relationships with commercial interests have been stated as noted by the following planners, presenters and moderators:

2Al Badarin, Firas
Speakers Bureau: Lantheus

2Beanlands, Rob
Consulting Fee: Lantheus Medical Imaging Jubilant DRAXImage
Research Grant or Contractor: Lantheus Medical Imaging Jubilant DRAXImage, GE Healthcare

1,2,3Calnon, Dennis
Consulting Fee: Navidea Biopharmaceuticals
Research Grant or Contractor:

1,2Di Carli, Marcelo
Research Grant or Contractor: Spectrum Dynamics
Advisory Board: Sanofi

1,2,3Dorbala, Sharmila
Research Grant or Contractor: Astellas
Stock Interest: General Electric

1,2,3Einstein, Andrew
Consulting Fee: GE Healthcare
Research Grant or Contractor: Philips, Toshiba

13Garcia Mario
Royalty: Elsevier, Wolters-Kluwer
Stock Interest: Pfizer

1,3Gropler, Robert
Consulting Fee: Sanofi
Research Grant or Contractor: Bayer, NIH, Biomedical

1,2Hage, Fadi
Research Grant or Contractor: Astellas, Novartis

1,2,3Hansen, Christopher
Consulting Fee: Digirad
Royalty: General Electric

1,3Mahmarian, John
Consulting Fee: Astellas, Inc
Speakers Bureau: Astellas, Inc

2Mann, April
Advisory Board: Astellas Pharma USA

1,2,3Miller, Edward
Consulting Fee: GE, Inc
Research Grant or Contractor: Bracco, Inc

1,2,3Pagnanelli, Robert
Speakers Bureau: Astellass

.

.

1,3Parker, Matthew
Consulting Fee: Intersocietal Accreditation Commission-PET/Nuclear peer review

1,2,3Russell, Raymond
Stock Interest: Novartis (spouse)
Salaried Employee: Novartis (spouse)

1,3Shah, Nishant
Stock Interest: General Electric

1Scholte, Arthur
Consulting Fee: Toshiba Medical Systems
Advisory Board: GE Healthcare

1,2,3Soman, Prem
Research Grant or Contractor: Astellas
Advisory Board: Alnylam Pharma

1,2,3Udelson, James
Advisory Board: Lantheus

.

.

.

.

.


.

.


Disclaimer
The information in this activity represents the opinion of the faculty and is not necessarily the official position of ASNC.

Policy on Off Label Use

Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented. Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

Method of Participation and CME Certificates
To receive CME credit for this product, you must:

  1. Purchase the product.
  2. Read the CME front matter.
  3. View the session(s) of your choosing.
  4. Click the CE Information tab on individual sessions, and the Test button.
  5. Complete the post-test. Your must score 75% to earn credit. You may take the test as many times as you need to score 75%.
  6. When you are finished watching the session of your choosing, your certificate will reflect the total accumulated credits from the session. Generate and print your CME certificate.
  7. If you would like a transcript, or a breakdown of all credits claimed across all the ASNC2017 content, visit the My Account area and click on the tab on the left labeled Certificates and Transcripts. As you take more sessions, this transcript will automatically update with the additional credtis.

Medium or Combination of Medium Used:
This is an on demand activity with slides synchronized with audio.

Commercial Acknowledgement
This activity has not received commercial support

Hardware/Software Requirements
For the most current list of system requirements, please visit http://asnc.digitellinc.com/asnc/support/faq

For technical support please contact:

support@digitellinc.comor (716)338-0332 ; Toll Free (877)796-1325 (U.S.A. only)

ASNC Contact Information:

American Society of Nuclear Cardiology
4340 East-West Highway, Suite 1120
Bethesda, MD 20814-4578
Phone: (301) 215-7575
Fax: (301) 215-7113
info@asnc.org

Privacy Policy

This website is provided by Digitell Inc. We do not share information about individuals with anyone other than the credit card processors and the shipping company.

The complete Privacy Policy can be found by clicking Privacy Policy at the bottom of http://asnc.digitellinc.com/asnc.

Moderator(s): Speaker(s):
Tags: Advanced
Standard: $75.00
Members: $25.00

Nuclear Cardiology Laboratory in 2017

Preview Available

Nuclear Cardiology Laboratory in 2017


Learning Objectives:

  • Understand basic overview of attenuation correction, the potential pitfalls and how to optimise practice
  • Attendees will learn sources of radiation in Cardiac PET, SPECT and CT
  • Attendees will review the principles of ALARA and how to apply them to diagnostic testing
  • Attendees will learn practical strategies for reducing patient and staff radiation dose based on nationally and internationally recognized standards

10:30 - 10:45 - ImageGuide: How it can Improve Your Practice

10:45 - 11:00 - ALARA: Practical Approaches to Radiation Reduction

11:00 - 11:15 - Lab Accreditation: Nuts and Bolts

11:15 - 11:30 - Optimizing Attenuation Correction and Reconstruction

11:30 - 11:45 - Advances in Nuclear Camera Technology

11:45 - 12:00 - Discussion

Moderator(s): Speaker(s):
Tags: Core

99mcTc-PYP Amyloid Imaging; PET for Inflammation/Infection

Preview Available

99mcTc-PYP Amyloid Imaging; PET for Inflammation/Infection


Learning Objectives:

  • For prosthetic valve infection and endocarditis, FDG PET/CT increases the sensitivity of Duke Criteria in diagnosing endocarditis, without compromising specificity
  • Understand the use of Tc99m PYP imaging in the evaluation of cardiac amyloidosis

10:30 - 12:00 - Case Presenters

Moderator(s): Speaker(s):
Tags: RWTE

Not Just Pushing Buttons

Preview Available

Not Just Pushing Buttons


Learning Objectives:

  • To understand the effect of filter parameters in image quality

10:30 - 11:00 - Acquisition Parameters (Conventional and Solid State)

11:00 - 11:30 - Processing Parameters (Conventional and Resolution Recovery)

11:30 - 12:00 - Types of Filters and Their Parameters

Moderator(s): Speaker(s):